Abstract:Baculovirus has been widely used for the production of recombinant proteins in insect cells. The extremely high yield by baculovirus-infected insect cells or larvae makes it an attractive tool for pharmaceutical protein production. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. Although AcMNPV (Autographa californica multiple NPV) fails to replicate in vertebrate cells, it does express alien genes with levels of expression that are dependent on the strength of the promoter used to drive transcription of the foreign gene. Following these findings, subsequent studies have rapidly expanded the list of permissive cells that include cell lines originating from human, rodent, porcine, bovine and even fish sources. Many tries have been done to study the mechanism of baxulovirus entry into mammalian cells, but the events responsible for virus uptake and detailed mechanisms of intracellular movement and nuclear entry of the virus are still largely unknown. The application of modified baculoviruses for in vivo gene delivery has also been demonstrated. In contrast to other commonly used viral vectors, baculoviruses have the unique property of being incapable of initiating a replication cycle and producing infectious virus in mammalian cells. The AcMNPV genome is large, thus rendering the virus flexibility to carry multiple genes or large inserts. The recombinant viruses can be readily constructed and produced to high titers simply by infecting insect cells, initiate little to none microscopically observable cytopathic effects on mammalian cells and have a good biosafety profile. These attributes will undoubtedly lead to the increased application and continued development of this system for efficient gene delivery into mammalian cells.

Attenuated MuV-S79 as vector stably expressing foreign gene

Establishment of an Efficient Reverse Genetic System of Mumps Virus S79 from Cloned DNA

Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein

Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses

A novel application of baculovirus in mammalian gene therapy]

Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery

Development and characterization of a recombinant Senecavirus A expressing enhanced green fluorescent protein

Construction of a new type of pseudotyped murine leukemia retrovirus vector(VSV-G/MuLV)

Generation of Recombinant Vaccinia Viruses Via Green Fluorescent Protein Selection

Infectious bursal disease virus as a replication-incompetent viral vector expressing green fluorescent protein

[Expression of the Infectious Bursal Disease Virus Polyprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier].

Recombinant measles virus incorporating heterologous viral membrane proteins for use as vaccines

An Enhanced Retroviral Vector for Efficient Genetic Manipulation and Selection in Mammalian Cells

Expression of H5N1 influenza virus hemagglutinin protein fused with protein transduction domain in an alphavirus replicon system.

Construction of Transferring Vector of Marek's Disease Virus Expressing GFP Gene and Its Primary Application

Immobilization of Foreign Protein into BmNPV Polyhedra Through Fusion with Partial Polyhedrin Fragment

Novel Enhanced Mammalian Cell Transient Expression Vector via Promoter Combination

An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.

User-Friendly Replication-Competent MAdV-1 Vector System with a Cloning Capacity of 3.3 Kilobases

Identification of the subgenomic promoter of the coat protein gene of cucumber fruit mottle mosaic virus and development of a heterologous expression vector

Construction and Characterization of Recombinant CVI988 Expressing the Green Fluorescent Protein